Kate is an immunologist with over seven years of industry experience. Her work bridges fundamental immunology and preclinical drug development, with a focus on bringing innovative therapies to patients with immune-mediated disorders. She earned her PhD in Virology from Harvard University. She also holds an MS in Chemistry from UC San Diego and a BS in Microbial Biology from UC Berkeley.